SDSamfee Doe

Samfee Doe

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Samfee Doe has a total of 4 co-authors. Here are the top co-authors by number of shared publications:

  • Monique Swain

    Department of Obstetrics and Gynecology, Henry Ford Hospital, Detroit, MI; Department of General Surgery, Breast Surgical Oncology, Henry Ford Hospital, Detroit, MI

    2 shared publications
  • Shariska Petersen

    Department of Women’s Health Services Henry Ford Hospital Detroit MI USA

    1 shared publication
  • Shariska Petersen Harrington

    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, USA

    1 shared publication
  • Thomas Buekers

    Department of Women's Health Services, Breast Surgical Oncology, Henry Ford Hospital, 2799 W. Grand Blvd, Detroit, MI, 48202, USA

    1 shared publication

Latest Publications

  • Utilization of genetic testing in breast cancer treatment after implementation of comprehensive multi‐disciplinary care

    by Samfee Doe, Shariska Petersen, Monique Swain

    To evaluate the utilization of genetic testing after implementing a comprehensive multi‐disciplinary care (cMDC) program for breast cancer and to assess for racial disparities. This retrospective study included patients newly diagnosed with invasive breast cancer 1 year before and 1 year after implementing a cMDC program to assess the rate of genetic referrals. Appropriate genetic referrals were defined by age, family history, triple‐negative status, and personal history based on National Comprehensive Cancer Network guidelines. Secondary outcomes included rates of recommended testing, actual testing, compliance, and equity in genetic referrals across demographics (race, insurance type, and hospital site). Statistical analyses used the Fisher exact test or chi‐square test. The 431 patients identified included 116 non‐cMDC and 315 cMDC patients. Following implementation of cMDC, a significant increase occurred not only in appropriate genetic referrals (35.3%‐55.5%) but also in inappropriate referrals (1.7%‐15.5%) (P = .001). Overall attendance increased among both cohorts, Caucasians were more compliant with attending their genetic appointment compared to their African American counterparts (non‐cMDC P = .025, cMDC P = .004). In the cMDC group, African Americans demonstrated a 6% increase in attendance compared to a 2% decrease among Caucasians. More appropriate genetic referrals were made to those with private insurance following implementation of cMDC. Utilizing a cMDC approach to breast cancer care may help increase appropriate utilization of genetics.